Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of LPS or aldesleukin on immune cell metabolism in healthy volunteers
NL-OMON58361Recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Feb 2026
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of lipopolysaccharide endotoxin and aldesleukin (2 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Intracellular immune-cell changes after activation, Immune mediator production and 1 more. Started Feb 2026; status: recruiting.
02
Drugs
lipopolysaccharide endotoxinaldesleukin
Beyond the preview
Go deeper on NL-OMON58361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58361.